-
Time Magazine - Fri Nov 27, 5:40 am ET
After years of complications and high-profile setbacks, a series of small but intriguing advances has suggested that gene therapy may hold real future potential for treatment
-
redOrbit - Wed Dec 2, 2:09 am ET
AMSTERDAM, December 2 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, announced today a number of management changes.
-
PR Newswire via Yahoo! Finance - Mon Nov 30, 9:07 am ET
Reportlinker.com announces that a new market research report is available in its catalogue:
-
PR Newswire via Yahoo! Finance - Wed Dec 2, 7:00 am ET
Gamida Cell announced today a feasibility study evaluating the preclinical safety and efficacy of a gene therapy product which combines technology from Weill Cornell Medical College and Gamida Cell.
-
GenomeWeb News - Sat Nov 28, 5:15 pm ET
The facility consists of a two-story administrative wing and a three-story research wing, set to seek certification from the US Green Building Council’s Leadership in Energy and Environmental Design or LEED program.
-
Rancho Santa Fe Record - Thu Nov 19, 5:59 pm ET
Using a gene-therapy delivery system developed in the laboratory of Inder Verma at the Salk Institute for Biological Studies, an international research team successfully treated two boys from Spain suffering from adrenoleukodystrophy (ALD), the rare, inherited disease that was the focus of the Hollywood film "Lorenzo's Oil." The genetic disorder, in which the fatty insulation of nerve cells ...
-
redOrbit - Tue Nov 24, 1:07 pm ET
Image Caption: This image shows the effect of gene therapy combined with cytotoxic agents in E spheroids derived from breast cancer cell line MCF-7. A. Control; B. Doxorubicin 10nm, C. Paclitaxel 10nm, D. Docetaxel 10nm, combined with gene E. Credit: University of Granada
-
EurekAlert! - Tue Nov 24, 10:01 am ET
( University of Granada ) The gene in question is a suicide gene, called "gene E," which leads to the death of tumor cells derived from breast, lung and colon cancer, and prevents their growth. Chemotherapy, radiotherapy and surgery show "limited" results in advanced stages of cancer, so the kind of gene therapy proposed by the scientists of the UGR is a huge breakthrough in cancer treatment.
-
KVOA Tucson - Mon Nov 23, 11:12 am ET
Around the world, there are more than 1,500 gene therapy trials going on to treat everything from Parkinson's to blindness to clogged arteries. Could the key to healing be in the body's building blocks?
-
EurekAlert! - Tue Nov 17, 12:35 pm ET
( The Mount Sinai Hospital / Mount Sinai School of Medicine ) Mount Sinai School of Medicine is one of 12 sites nationwide participating in the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study is the first multicenter neurosurgical intervention in Alzheimer's research in the US.
-
Newswise - Mon Nov 16, 12:57 pm ET
Researchers are preparing for the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer's disease. The study, the first multicenter neurosurgical intervention in Alzheimer's research in the U.S., utilizes a viral-based gene transfer system, CERE-110, that makes Nerve Growth Factor (NGF), a naturally occurring protein that helps maintain nerve cell survival in the brain.
-
MedicineNet.com - Fri Nov 13, 4:31 pm ET
Title: Gene Therapy Brings New Muscle to Monkeys Category: Health News Created: 11/12/2009 12:10:00 PM Last Editorial Review: 11/13/2009
-
redOrbit - Wed Nov 18, 4:08 am ET
AMSTERDAM, November 18 /PRNewswire-FirstCall/ -- - Glybera(R) Clinical Data Presented at Meeting of American Heart Association Amsterdam Molecular Therapeutics (EuroNext Amsterdam: AMT), a leader in the field of human gene therapy, today provides its non-audited business update in compliance with the EU transparency directive.
-
Reuters via Yahoo! News - Wed Nov 11, 2:42 pm ET
A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday.
-
The Columbus Dispatch - Thu Nov 12, 4:03 am ET
A gene-therapy experiment in monkeys has shown the ability to boost muscle size and strength, giving hope to those looking for treatments for muscular dystrophy and other diseases that cause muscle loss and weakness.